文献速递临床试验与 GCP医学教育与科研方法

Sleeping for Two:孕期失眠认知行为治疗随机对照试验的研究方案

Sleeping for two: study protocol for a randomized controlled trial of cognitive behavioral therapy for insomnia in pregnant women.
PubMed 文献 · Trials · 2021-08-12

本研究为双臂、单盲、平行组随机对照试验,计划纳入62名孕12至28周自述失眠的孕妇,比较失眠认知行为治疗(CBT-I,面对面或远程医疗)与常规治疗(TAU)的效果。主要结局为失眠症状改善,次要结局包括延长孕周和减轻抑郁症状,评估在孕12至28周、治疗后1周及产后6个月进行。

要点

  • 孕期失眠常见,CBT-I或可同时改善失眠与抑郁并降低早产风险。
  • 试验采用单盲设计,CBT-I为5次每周个体治疗,可面对面或远程进行。
  • 评估工具包括结构化访谈、睡眠日记和体动记录仪。

核心结论

  • 孕期CBT-I有潜力减轻失眠和抑郁症状,并可能降低早产风险。
  • 本研究将评估CBT-I(面对面或远程)与常规治疗相比对孕期失眠的疗效。

研究设计与样本

  • 采用双臂、单盲、平行组随机对照试验设计,重复测量。
  • 计划纳入62名孕12至28周自述失眠的孕妇。
  • CBT-I组接受5次每周个体治疗,方式可面对面或远程。

主要发现

  • 主要结局为失眠症状改善,次要结局包括孕周延长和抑郁症状减轻。
  • 评估在孕12至28周(T1)、治疗后1周(T2)、产后6个月(T3)进行。

临床怎么用

  • CBT-I可在孕期通过面对面或远程方式提供,以改善失眠和抑郁。
  • 治疗可能有助于降低早产风险,从而减少母婴不良结局。

局限性

  • 研究样本量较小(62人),可能影响结果的普遍性。
  • 远程或面对面实施取决于物理距离指南,可能引入异质性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Insomnia and sleep disturbances are common in pregnancy and have potentially significant consequences for both maternal and infant health. There is limited research examining the effectiveness of cognitive behavioral therapy for insomnia (CBT-I) during pregnancy. With increased distress and limited access to services during the COVID-19 pandemic, there is also an unprecedented need for telehealth delivery of treatment programs for pregnant women. The aims of this trial are to evaluate the impact of the Sleeping for Two adaptation of CBT-I in pregnancy (in-person or telehealth) versus treatment as usual (TAU) in reducing symptoms of insomnia (primary outcome), as well as increasing gestational length and reducing symptoms of depression (secondary outcomes). METHODS: A two-arm, single-blinded, parallel group randomized controlled trial (RCT) design with repeated measures will be used to evaluate the impact of CBT-I compared to TAU among a sample of 62 pregnant women, enrolled between 12 and 28 weeks of gestation, who self-identify as experiencing insomnia. Five weekly individual sessions of CBT-I will be delivered in person or via telehealth depending on physical distancing guidelines. Assessment of insomnia diagnosis by structured interview, self-reported insomnia symptom severity and sleep problems, and sleep quantity and quality as measured by a daily diary and actigraphy will occur at 12-28 weeks of pregnancy (T1), 1 week post-treatment (T2), and 6 months postpartum (T3). DISCUSSION: CBT-I delivered in pregnancy has the potential to reduce symptoms of insomnia and depression and could lead to reduced risk of preterm birth, all of which can minimize risk of negative maternal and child health and developmental consequences in the short (e.g., infant death) and long terms (e.g., developmental delays). This RCT builds on a successful open pilot trial conducted by our team and will provide further evaluation of a novel evidence-based treatment for pregnancy-related insomnia, which can be widely disseminated and used to treat individuals that are most in need of intervention. Findings will enhance understanding of pregnancy-related sleep problems, as well as means by which to improve the health and sleep of mothers and their children. TRIAL REGISTRATION: ClinicalTrials.gov NCT03918057. Registered on 17 April 2019.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. MacKinnon AL, Madsen JW, Dhillon A, et al. Sleeping for two: study protocol for a randomized controlled trial of cognitive behavioral therapy for insomnia in pregnant women. Trials. 2021. PMID: 34384459. doi:10.1186/s13063-021-05498-w

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。